Entero Therapeutics Inc (ENTO)
2.07
-0.13
(-5.91%)
USD |
NASDAQ |
Jun 14, 16:00
2.07
0.00 (0.00%)
After-Hours: 20:00
Entero Therapeutics Cash from Operations (Quarterly): -3.747M for March 31, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -3.747M |
| December 31, 2023 | -3.439M |
| September 30, 2023 | -3.331M |
| June 30, 2023 | -2.762M |
| March 31, 2023 | -2.846M |
| December 31, 2022 | -5.592M |
| September 30, 2022 | -4.254M |
| June 30, 2022 | -4.586M |
| March 31, 2022 | -7.912M |
| December 31, 2021 | -5.863M |
| September 30, 2021 | -15.73M |
| June 30, 2021 | -5.623M |
| March 31, 2021 | -5.073M |
| December 31, 2020 | -5.89M |
| September 30, 2020 | -2.697M |
| June 30, 2020 | -1.344M |
| March 31, 2020 | -1.291M |
| December 31, 2019 | -3.226M |
| September 30, 2019 | -4.154M |
| Date | Value |
|---|---|
| June 30, 2019 | -4.026M |
| March 31, 2019 | -2.628M |
| December 31, 2018 | -3.341M |
| September 30, 2018 | -2.666M |
| June 30, 2018 | -2.648M |
| March 31, 2018 | -2.214M |
| December 31, 2017 | -2.469M |
| September 30, 2017 | -1.293M |
| June 30, 2017 | -2.257M |
| March 31, 2017 | -1.165M |
| December 31, 2016 | -2.017M |
| September 30, 2016 | -1.226M |
| June 30, 2016 | -0.6554M |
| March 31, 2016 | -0.6365M |
| December 31, 2015 | -0.7172M |
| September 30, 2015 | -1.747M |
| June 30, 2015 | -0.6799M |
| March 31, 2015 | -1.026M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-15.73M
Minimum
Sep 2021
-1.291M
Maximum
Mar 2020
-4.669M
Average
-4.090M
Median
Cash from Operations (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | -1.572M |
| Palatin Technologies Inc | -8.607M |
| iBio Inc | -3.654M |
| Theriva Biologics Inc | -4.881M |
| Oragenics Inc | -3.064M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 0.0882M |
| Cash from Financing (Quarterly) | 3.379M |
| Free Cash Flow | -13.28M |
| Free Cash Flow Per Share (Quarterly) | -0.2582 |
| Free Cash Flow Yield | -154.9% |